OpenAI launches GPT-Rosalind for life sciences research
aihealthcare
feature announcement
OpenAI has introduced GPT-Rosalind, a new reasoning model designed to speed up scientific research in areas like drug discovery and genomics. This model aims to improve workflows for analyzing proteins and performing genetic analysis. It is positioned as a frontier model for accelerating life sciences research.
Features (1) ›
- GPT-Rosalind model for life sciences research
OpenAI has launched GPT-Rosalind, a frontier reasoning model specifically developed to accelerate research in drug discovery, genomics analysis, and protein reasoning. The model is intended to enhance scientific research workflows.
Read the original announcement →
https://openai.com/index/introducing-gpt-rosalind
Related releases
- OpenAI Disrupts Cambodia-Based Scam Operation OpenAI News ·
- openai-python v2.52.0 adds content provenance checks OpenAI Python SDK Releases ·
- OpenAI's Full-Stack Approach to Advanced AI OpenAI News ·
- Univé Builds AI-Ready Workforce with ChatGPT Enterprise OpenAI News ·
- OpenAI Discusses Responsible AI Practices for Europe OpenAI News ·
- Avatarin uses OpenAI GPT-Realtime for 24/7 retail customer support OpenAI News ·